Excel Genetics Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
as on 11-12-2024
- Paid Up Capital ₹ 7.00 Cr
as on 11-12-2024
- Company Age 18 Year, 20 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.17 Cr
as on 11-12-2024
- Revenue -28.34%
(FY 2023)
- Profit -64.85%
(FY 2023)
- Ebitda -31.77%
(FY 2023)
- Net Worth 19.10%
(FY 2023)
- Total Assets 12.19%
(FY 2023)
About Excel Genetics
The Corporate was formerly known as Harvest Inte-Agro Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 7.00 Cr.
The company currently has active open charges totaling ₹2.17 Cr.
Paresh Saraiya, Anil Kakkar, Abhay Saraiya, and One other member serve as directors at the Company.
- CIN/LLPIN
U02412GJ2006PLC049495
- Company No.
049495
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
30 Nov 2006
- Date of AGM
12 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Excel Genetics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhay Saraiya  | Managing Director | 01-Apr-2016 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anil Kakkar | Director | 25-Sep-2015 | Current |
| Paresh Saraiya | Director | 30-Nov-2006 | Current |
| Ami Shroff | Director | 25-Sep-2015 | Current |
Financial Performance and Corporate Structure Insights of Excel Genetics.
Excel Genetics Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 28.34% decrease. The company also saw a substantial fall in profitability, with a 64.85% decrease in profit. The company's net worth Soared by an impressive increase of 19.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Excel Genetics?
In 2023, Excel Genetics had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Jul 2020 | ₹1.65 M | Open |
Others Creation Date: 04 Jan 2012 | ₹2.00 Cr | Open |
How Many Employees Work at Excel Genetics?
Excel Genetics has a workforce of 25 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Excel Genetics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Excel Genetics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
